Martin Wendlassida NACANABO

Dr. Martin Wendlassida NACANABO


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in BMC Rheumatology
Verified
Journal Article
Open access
PDF file
YBYannick Laurent Tchenadoyo BAYALA
Yannick Laurent Tchenadoyo BAYALA
WZWendlassida Joelle Stéphanie Zabsonré/Tiendrebeogo
Wendlassida Joelle Stéphanie Zabsonré/Tiendrebeogo
DODieu-Donné Ouedraogo
Dieu-Donné Ouedraogo
FKFulgence Kaboré
Fulgence Kaboré
CSCharles Sougué
Charles Sougué
YZYamyellé Enselme Zongo
Yamyellé Enselme Zongo
Artificial intelligence (AI) tools, particularly Large Language Models (LLMs), are revolutionizing medical practice, including rheumatology. However, their diagnostic capabilities remain underexplored in the African context. To assess the diagnostic accuracy of ChatGPT-4, Gemini, Copilot, and Claude AI in rheumatology within an African population. This was a cross-sectional analytical study with retrospective data collection, conducted at the Rheumatology Department of Bogodogo University Hospital Center (Burkina Faso) from January 1 to June 30, 2024. Standardized clinical and paraclinical data from 103 patients were submitted to the four AI models. The diagnoses proposed by the AIs were compared to expert-confirmed diagnoses established by a panel of senior rheumatologists. Diagnostic accuracy, sensitivity, specificity, and predictive values were calculated for each AI model. Among the patients enrolled in the study period, infectious diseases constituted the most common diagnostic category, representing 47.57% (n = 49). ChatGPT-4 achieved the highest diagnostic accuracy (86.41%), followed by Claude AI (85.44%), Copilot (75.73%), and Gemini (71.84%). The inter-model agreement was moderate, with Cohen’s kappa coefficients ranging from 0.43 to 0.59. ChatGPT-4 and Claude AI demonstrated high sensitivity (> 90%) for most conditions but had lower performance for neoplastic diseases (sensitivity < 67%). Patients under 50 years old had a significantly higher probability of receiving a correct diagnosis with Copilot (OR = 3.36; 95% CI [1.16–9.71]; p = 0.025). LLMs, particularly ChatGPT-4 and Claude AI, show high diagnostic capabilities in rheumatology, despite some limitations in specific disease categories. Not applicable.

9 December 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MNMartin Wendlassida NACANABO
Martin Wendlassida NACANABO
YBYannick Laurent Tchenadoyo BAYALA
Yannick Laurent Tchenadoyo BAYALA
ASAndré Arthur Taryètba Seghda
André Arthur Taryètba Seghda
ATAnna Tall/Thiam
Anna Tall/Thiam
AYAristide Relwendé Yaméogo
Aristide Relwendé Yaméogo
PZPatrice Zabsonré
Patrice Zabsonré
Artificial intelligence, particularly Large Language Models (LLMs), has revolutionized the field of medicine. Their ability to understand and answer medica

7 May 2025 in Health Science Reports
Verified
Journal Article
Open access
MNMartin Wendlassida NACANABO
Martin Wendlassida NACANABO
TSTaryètba André Arthur Seghda
Taryètba André Arthur Seghda
DDDjième Claudine Dah
Djième Claudine Dah
MLMureille Loya
Mureille Loya
LTLamoudi Prisca Thiombiano
Lamoudi Prisca Thiombiano
PZPartice Zabsonre
Partice Zabsonre
Introduction/Objective: Floating thrombus of the right heart chambers is an uncommon diagnosis and is systematically associated with pulmonary embolism. The aim of this study is to describe the management and evolution of right intracavitary thrombi (TIC) in pulmonary embolism. Materials and Method: This was a prospective cohort that ran for 76 months from March 5, 2017 to July 31, 2023. Patients diagnosed with pulmonary embolism were included. Two population groups were established according to the presence or absence of right intracavitary thrombus on Doppler echocardiography (intracavitary thrombi+ vs. intracavitary thrombi−) permitted to compare the risks factors. Thromboembolic risk factors, including the patient's background and clinical, paraclinical, therapeutic and evolutionary aspects, were reported. A significance level of p < 0.05 was used for data analysis. Results: The prevalence of emboli associated with intracavitary thrombi was 2.98%. Arterial hypotension, right ventricular dilatation, and deaths were significantly associated with right chamber thrombi with p = 0.0051 (OR: 4.14; IC 95%: 1.53–11.2); 0.0015 (OR: 4.4; IC 95%: 1.76–10.9); 0.00 (OR: 9.21; IC 95%: 3.69–23.3); 0.0313 (OR: 3.16; IC 95%: 1.10–9.02), respectively. Thrombolysis was performed in 70.58% of patients in the intracavitary thrombi+ group, compared with 11.93% in the intracavitary thrombi− group. The presence of intracavitary thrombi+ was associated with a high mortality rate of 35.29% compared with 9.82% in the intracavitary thrombi− group. Conclusion: The discovery of a thrombus of the right heart, although rare, is not exceptional. Their management is the subject of controversy between learned societies. Thrombolysis is the only therapeutic option in this context.

3 September 2024
Verified
Journal Article
Open access
MNMartin Wendlassida NACANABO
Martin Wendlassida NACANABO
TSTaryètba André Arthur Seghda
Taryètba André Arthur Seghda
DDDjième Claudine Dah
Djième Claudine Dah
WSWendlassida Léa Françoise Sawadogo
Wendlassida Léa Françoise Sawadogo
ISIssa Sawadogo
Issa Sawadogo
ASAndré Koudnoaga Samadoulougou
André Koudnoaga Samadoulougou
Hypertensive emergencies are defined as hypertensive crisis with signs of visceral distress. They are relatively common and require urgent, but not necessarily normotensive, antihypertensive therapy. The aim of this study was to describe the epidemiology of hypertensive emergencies.. This was a descriptive cross-sectional study conducted from March 5, 2017, to December 31, 2023, at the cardiology department of the Bogodogo University Hospital (CHU-B), Burkina Faso. All patients admitted to the department for hypertensive emergencies were included in the study. Epidemiologic, sociodemographic, clinical, paraclinical, therapeutic, and evolutionary characteristics were evaluated in a descriptive analysis. Among 2,610 hospitalized patients, 96 cases of hypertensive emergencies were identified, representing a prevalence of 3.6%. Mean age was 50.5 (±10.4) years. Cardiovascular risk factors were hypertension, sedentary lifestyle, diabetes, and smoking in 80.8%, 72.3%, 12.7%, and 9.5% of cases, respectively. Headache was the most common reason for consultation (46.8% of cases), followed by dizziness (19.1%). Ischemic stroke and acute pulmonary edema were observed in 18.7% of cases. Hypertensive emergencies are quite frequent at CHU-B and the majority of patients are relatively young.

26 May 2026 in Annales de Cardiologie et d'Angéiologie
Verified
Journal Article
Closed access
MNMartin Wendlassida NACANABO
Martin Wendlassida NACANABO
ASA.A.T. Seghda
A.A.T. Seghda
ATA. Tall Thiam
A. Tall Thiam
CDC.D. Dah
C.D. Dah
ISI. Sawadogo
I. Sawadogo
PZP. Zabsonre
P. Zabsonre

17 December 2025 in Clinical Case Reports
Verified
Journal Article
Open access
MNMartin Wendlassida NACANABO
Martin Wendlassida NACANABO
ASAndré Arthur Taryètba Seghda
André Arthur Taryètba Seghda
ATAnna Tall/Thiam
Anna Tall/Thiam
GMGeorges Christian Millogo
Georges Christian Millogo
VYValentin Nobila Yaméogo
Valentin Nobila Yaméogo
PZPatrice Zabsonré
Patrice Zabsonré
The discovery of non‐compaction cardiomyopathy of the left ventricle (NCVG), although rare, is not exceptional. This case involved a 36‐year‐old man admitted with palpitations, exertional dyspnea, hypersudation, and anxiety. The electrocardiogram revealed ventricular tachycardia. Transthoracic Doppler echocardiography and cardiac magnetic resonance imaging revealed hypertrabeculation of the left ventricle, with a ratio of noncompacted to compacted myocardium of 3.04. LVEF was 64%. The diagnosis of ventricular tachycardia revealing noncompaction of the left ventricle complicated by lateral ischemia was accepted. Anti‐arrhythmic treatment with external electric shock enabled sinus rhythm to be achieved with a good reduction in tachycardia.